Skip to main content
Download PDF

Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer

Journal of Ovarian Research volume 18, Article number: 15 (2025) Cite this article

The Original Article was published on 28 September 2024

Correction: J Ovarian Res 17, 190 (2024)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-024-01518-w

Following publication of the original article [1], the authors reported that the funding section was not included in the published article.

Funding

This work was supported by the Ministry of Science and Technology and the National Science and Technology Council of Taiwan (MOST111-2634-FA49-014, MOST111-2636-E-A49-006, MOST 111-2221-E-A49-130-MY3, NSTC112-2320-B016-008) and the Ministry of Health and Welfare (MOHW112-TDU-B-222-124013).

The original article [1] has been corrected.

References

  1. Chen SF, Wang LY, Lin YS, et al. Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer. J Ovarian Res. 2024;17:190. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-024-01518-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, 112, Taiwan

    Shuo-Fu Chen

  2. Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan

    Liang-Yun Wang & Cho-Yi Chen

  3. Program in Genetics and Genomics, Baylor College of Medicine, Houston, TX, 77030, USA

    Yi-Sian Lin

  4. Brain Research Center, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan

    Cho-Yi Chen

Authors
  1. Shuo-Fu Chen
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Liang-Yun Wang
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Yi-Sian Lin
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Cho-Yi Chen
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Cho-Yi Chen.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-024-01518-w.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, SF., Wang, LY., Lin, YS. et al. Correction: Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer. J Ovarian Res 18, 15 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-025-01605-6

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13048-025-01605-6

Journal of Ovarian Research

ISSN: 1757-2215

Contact us